Allogene Therapeutics Inc... (ALLO)
NASDAQ: ALLO
· Real-Time Price · USD
1.70
0.02 (1.19%)
At close: May 01, 2025, 3:59 PM
1.69
-0.59%
Pre-market: May 02, 2025, 04:47 AM EDT
Allogene Therapeutics Revenue
Allogene Therapeutics reported an annual revenue of $22K, reflecting a -76.84% growth. For the quarter ending December 31, 2024, Allogene Therapeutics generated $0 in revenue.
Revenue (ttm)
$22K
Revenue Growth
-76.84%
Price / Sales Ratio
18861.32
Revenue / Employee
$97.35
Employees
226
Market Cap
369.35M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|